cannabis indica

Saúde Mental e Emocional

termo de indexação original: Mental/Emotional System

O acervo do Cannabis Indica reúne 1.784 estudos científicos que tocam o Saúde Mental e Emocional, publicados entre 1871 e 2024. Pela leitura automatizada, 863 (48%) foram classificados como favoráveis, 395 (22%) como inconclusivos e 526 (29%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (824 estudos), seguido de ensaio clínico (329). As condições mais estudadas dentro deste sistema são Dependência Química, Efeitos Adversos da Cannabis e Dependência — Cannabis.

Estudos indexados
1.784
Período coberto
1871–2024
Favoráveis
863 · 48%
Inconclusivos
395 · 22%
Desfavoráveis
526 · 29%
Termo original
Mental/Emotional System

O acervo em números

Tipo de estudo

Metanálise824
Ensaio Clínico329
Estudo em Animais286
Ensaio Clínico Duplo-Cego228
Metanálise Clínica101
Estudo Laboratorial15
Ensaio Clínico Veterinário1

Direção do resultado

Favorável863
Inconclusivo395
Desfavorável526

Por década

1870s1
1880s2
1890s1
1900s1
1940s1
1970s3
1980s9
1990s17
2000s141
2010s603
2020s1.005

1.784 estudos

Filtrar e buscar no acervo →

Esta página mostra 309 dos 1.784 estudos indexados sobre o tema, dos mais recentes aos mais antigos. Abra o acervo com este filtro para percorrer todos, ou baixe a lista completa em JSON e CSV.

  1. 2024

    [Effectiveness of a cannabis prevention program in school: results of a randomized prospective study]

  2. 2024

    10.1016/j.addbeh.2023.107877 — título não disponível na fonte

  3. 2024

    A national study of clinical discussions about cannabis use among Veteran patients prescribed opioids

  4. 2024

    A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaDependência — Cannabis
  5. 2024

    A social media intervention for high-intensity drinking among emerging adults: a pilot randomized controlled trial

  6. 2024

    Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder: Exploratory Findings from a Randomized Controlled Trial

  7. 2024

    An intervention based on Well-Being Therapy to prevent alcohol use and other unhealthy lifestyle behaviors among students: a three-arm cluster randomized controlled trial

  8. 2024

    Assessing effects of Cannabis on various neuropathologies: A systematic review

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  9. 2024

    Association between cannabis use disorder and schizophrenia stronger in young males than in females

    InconclusivoMetanáliseDependência QuímicaDependência — CannabisPsicose+1
  10. 2024

    Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

    DesfavorávelMetanáliseAnsiedadeDepressãoDisfunção Cognitiva+5
  11. 2024

    Cannabidiol Therapy for Comorbid Schizophrenia and Addiction: A Guide for Clinical Practice

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisPsicose+7
  12. 2024

    Cannabinoid treatment for the symptoms of autism spectrum disorder

  13. 2024

    Cannabis induced gastrointestinal tract symptoms in the adult population: a systematic review

  14. 2024

    Clinical and Family Implications of Cannabidiol (CBD)-Dominant Full-Spectrum Phytocannabinoid Extract in Children and Adolescents with Moderate to Severe Non-Syndromic Autism Spectrum Disorder (ASD): An Observational Study on Neurobehavioral Management

    FavorávelEnsaio ClínicoAutismoTDA e TDAH
  15. 2024

    Clinical factors associated with smoking cessation among smokers with Chronic Obstructive Pulmonary Disease by sex: Longitudinal analyses from French smoking cessation services

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — NicotinaDPOC
  16. 2024

    Clinical Variables and Peripheral Biomarkers Associated with Substance-Induced Psychotic Disorder: Differences Related to Alcohol, Cannabis, and Psychostimulant Abuse

  17. 2024

    Clinical, sociodemographic and environmental predicting factors for relapse in bipolar disorder: A systematic review

    DesfavorávelMetanáliseDepressãoTranstorno Bipolar
  18. 2024

    Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth

  19. 2024

    Digital Interventions for Recreational Cannabis Use Among Young Adults: Systematic Review, Meta-Analysis, and Behavior Change Technique Analysis of Randomized Controlled Studies

  20. 2024

    Effect of a selective personality-targeted prevention program on 7-year illicit substance related outcomes: A secondary analysis of a cluster randomized controlled trial

  21. 2024

    Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisAnsiedade+4
  22. 2024

    Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Álcool
  23. 2024

    Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs

    FavorávelMetanáliseAnsiedadeAnandamida (AEA)Endocanabinoide (não especificado)+5
  24. 2024

    Endocannabinoid levels in female-sexed individuals with diagnosed depression: a systematic review

    InconclusivoMetanáliseAnsiedadeDepressãoPsicoseEndocanabinoide (não especificado)
  25. 2024

    Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoInsônia e Distúrbios do Sono+3
  26. 2024

    Examining the association between prenatal cannabis exposure and child autism traits: A multi-cohort investigation in the environmental influences on child health outcome program

    InconclusivoMetanáliseEfeitos Adversos da CannabisAutismoTDA e TDAH
  27. 2024

    Experimental Effects of Substance Use Legality (Sober, Alcohol, Marijuana, Cocaine) and Sexual Crime (Indecent Exposure, Rape) on Attributions of Perpetrator Responsibility, Blame, and Punishment

  28. 2024

    Harmonization of clinical practice guidelines for primary prevention and screening: actionable recommendations and resources for primary care

    InconclusivoMetanáliseDependência QuímicaCâncerDependência — Cannabis+12
  29. 2024

    Initial Results from a New College Substance Use Prevention Program Targeting Externalizing and Internalizing Traits

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Álcool
  30. 2024

    Morphological and clinical findings in placentas and newborns with a history of tobacco, alcohol, and other substance abuse during pregnancy

  31. 2024

    Neurolipidomic insights into anxiety disorders: Uncovering lipid dynamics for potential therapeutic advances

  32. 2024

    Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications

  33. 2024

    Patterns of Polysubstance Use in Young Black and Latinx Sexual Minority Men and Transgender Women and Its Association with Sexual Partnership Factors: The PUSH Study

  34. 2024

    Perceived Effectiveness of Cigar Warnings in Discouraging Blunt Use

  35. 2024

    Positive psychological interventions on alcohol use and consequences: Pilot randomized trial in a young adult cannabis-using sample

  36. 2024

    Problematic Consumption of Alcohol, Cannabis and Cigarettes—a German Nationwide Survey on Psychopathology, Stress, Mindfulness, and Quality of Life

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisPsicose+3
  37. 2024

    Process evaluation of a pragmatic feasibility trial on smokeless tobacco cessation intervention delivered in dental hospitals

  38. 2024

    Psychosexual dysfunction in male patients with cannabis dependence and synthetic cannabinoid dependence

  39. 2024

    Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder

  40. 2024

    Recent Advanced Methods for Extracting and Analyzing Cannabinoids from Cannabis-Infused Edibles and Detecting Hemp-Derived Contaminants in Food (2013-2023): A Comprehensive Review

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  41. 2024

    Results of a randomized controlled trial of the cannabis eCHECKUP TO GO personalized normative feedback intervention on reducing cannabis use, cannabis consequences, and descriptive norms

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis
  42. 2024

    Screening and Brief Intervention for Cannabis Misuse in Individuals on Buprenorphine Treatment for Opioid Use Disorder: Double-Blind Randomized Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  43. 2024

    Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile

  44. 2024

    Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in England

    InconclusivoMetanáliseDependência QuímicaDependência — CannabisPsicose+6
  45. 2024

    Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  46. 2024

    Systematic review: the impact of maternal pre-and postnatal cannabis use on the behavioral and emotional regulation in early childhood

  47. 2024

    The Effect of Nabiximols on Driving Ability in Adults with Chronic Tic Disorders: Results of a Substudy Analysis of the Double-Blind, Randomized, Placebo-Controlled CANNA-TICS Trial

  48. 2024

    The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies

  49. 2024

    The Impact of Recreational Marijuana Legalization on Intimate Partner Violence

    FavorávelMetanáliseViolência DomésticaTranstorno Explosivo Intermitente
  50. 2024

    The prevalence of cannabis use disorder in attention-deficit hyperactivity disorder: A clinical epidemiological meta-analysis

    DesfavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  51. 2024

    The Therapeutic Potential of Cannabidiol in Revolutionising Opioid Use Disorder Management

  52. 2024

    The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders

    FavorávelMetanáliseDorInflamaçãoEpilepsiaEndocanabinoide (não especificado)+3
  53. 2024

    Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue

    FavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDepressão+3
  54. 2024

    Using Smartphone Technology to Track Real-Time Changes in Anxiety/Depression Symptomatology Among Florida Cannabis Users

    FavorávelMetanáliseAnsiedadeDepressão
  55. 2023

    "Letting Go and Staying Connected": Substance Use Outcomes from a Developmentally Targeted Intervention for Parents of College Students

  56. 2023

    [Diffuse alveolar hemorrhage in cannabis smokers. A systematic literature review]

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  57. 2023

    A - 93 The Impact of Motivation on Neuropsychological Performance in Chronic Cannabis Users

  58. 2023

    A case of panic attack developing after THC-O acetate inhalation using an e-cigarette device

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDepressão+5
  59. 2023

    A Case of Panic Attacks Developing After 10 Years of Chronic Cannabis Use in a Patient With No Prior Psychiatric History

    DesfavorávelMetanáliseDorCâncerInflamaçãoTetraidrocanabinol (THC)Canabigerol (CBG)+14
  60. 2023

    A Double-Blind, Randomized, Placebo-Controlled Test of the Effects of Cannabidiol on Experiences of Test Anxiety Among College Students

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedade
  61. 2023

    A guided digital intervention to reduce cannabis use: The ICan randomized controlled trial

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  62. 2023

    A remote brief intervention plus social media messaging for cannabis use among emerging adults: A pilot randomized controlled trial in emergency department patients

  63. 2023

    A small clinical trial of vaporized cannabis for PTSD: suggestive results and directions for future study

    FavorávelEnsaio Clínico Duplo-CegoTEPT
  64. 2023

    A systematic review and meta-analysis of the association between young adults' sleep habits and substance use, with a focus on self-medication behaviours

  65. 2023

    A systematic review of brief, freely accessible, and valid self-report measures for substance use disorders and treatment

  66. 2023

    Alleviation of Pain, PAIN Interference, and Oxidative Stress by a Novel Combination of Hemp Oil, Calamari Oil, and Broccoli: A Randomized, Double-Blind, Placebo-Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDependência QuímicaInflamaçãoÔmega-3+3
  67. 2023

    Amphetamine use and its associations with antiretroviral adherence and viral load among sexual minority men and transgender women living with HIV

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Álcool+3
  68. 2023

    An on-line school-based substance use harm reduction programme: The Illicit Project randomized controlled trial results

  69. 2023

    Assessing changes in sleep across four weeks among adolescents randomized to incentivized cannabis abstinence

  70. 2023

    Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadeDisfunção CognitivaTetraidrocanabinol (THC)
  71. 2023

    Assessment of Screening Tools to Identify Substance Use Disorders Among Adolescents

  72. 2023

    Associations of Momentary Mindfulness With Affect and Cannabis Desire in a Trial of Cannabis Use Interventions With and Without Momentary Assessment

  73. 2023

    Associations of psychoactive substances and steroid hormones in hair: Findings relevant to stress research from a large cohort of young adults

  74. 2023

    Associations of the P300 Event-Related Potentials and Self-Reported Craving in Substance Use Disorders: A Systematic Review

  75. 2023

    Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review

  76. 2023

    Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis

    FavorávelMetanálise ClínicaInflamaçãoPsicoseAnandamida (AEA)
  77. 2023

    Bridging the gap between genetic epidemiological research and prevention: A randomized control trial of a novel personalized feedback program for alcohol and cannabis use

  78. 2023

    Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies

    FavorávelMetanáliseDorDependência QuímicaDependência — Opioides+4
  79. 2023

    Cannabidiol Analogue CIAC001 for the Treatment of Morphine-Induced Addiction by Targeting PKM2

    FavorávelEstudo LaboratorialDependência QuímicaInflamaçãoDependência — Opioides
  80. 2023

    Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisAnsiedade+7
  81. 2023

    Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study

    FavorávelEnsaio Clínico Duplo-CegoDepressão
  82. 2023

    Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over study

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  83. 2023

    Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state

    FavorávelMetanáliseDisfunção CognitivaPsicoseEsquizofreniaAnandamida (AEA)+1
  84. 2023

    Cannabidiol safety considerations: Development of a potential acceptable daily intake value and recommended upper intake limits for dietary supplement use

  85. 2023

    Cannabidiol tempers alcohol intake and neuroendocrine and behavioural correlates in alcohol binge drinking adolescent rats. Focus on calcitonin gene-related peptide's brain levels

    FavorávelEstudo em AnimaisDependência QuímicaAnsiedadeDependência — Álcool+1
  86. 2023

    Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats

    FavorávelEstudo em AnimaisDepressãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
  87. 2023

    Cannabis and Psychosis.

    DesfavorávelMetanálisePsicose
  88. 2023

    Cannabis use disorders and outcome of admission to intensive care: A retrospective multi-centre cohort study

    InconclusivoEnsaio ClínicoDependência QuímicaDependência — Cannabis
  89. 2023

    Cannabis use in Attention - Deficit/Hyperactivity Disorder (ADHD): A scoping review

    InconclusivoMetanálisePsicoseTDA e TDAH
  90. 2023

    Cannabis use in sub-Saharan Africa: A systematic review and meta-analysis

    InconclusivoMetanáliseDependência QuímicaDependência — Cannabis
  91. 2023

    Cannabis-Induced Acute Encephalopathy in a 94-Year-Old Woman Due to Family Administration of Cannabidiol (CBD) Products: A Case Report

  92. 2023

    Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination-the SPIRAL study

  93. 2023

    Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review

    FavorávelMetanáliseDependência QuímicaDependência — Opioides
  94. 2023

    Co-use of cigarettes and cannabis among people with HIV: Results from a randomized controlled smoking cessation trial

  95. 2023

    Cocaine-Induced Raynaud's Phenomenon: A Case Report

  96. 2023

    Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study

    FavorávelMetanáliseDorAnsiedadeDor — Crônica
  97. 2023

    Comparing the Efficacy of Mindfulness-Based Relapse Prevention Versus Relapse Prevention for Alcohol Use Disorder: A Randomized Control Trial

  98. 2023

    Comparison of the influence of alcohol and cannabis on the dynamics of the accommodative response

  99. 2023

    County-level predictors of US drug overdose mortality: A systematic review

    InconclusivoMetanáliseDependência QuímicaDependência — Opioides
  100. 2023

    Cross-substance primed and cue-induced craving among alcohol and cannabis co-users: An experimental psychopharmacology approach

  101. 2023

    Daily Cannabidiol Administration for 10 Weeks Modulates Hippocampal and Amygdalar Resting-State Functional Connectivity in Cannabis Users: A Functional Magnetic Resonance Imaging Open-Label Clinical Trial

  102. 2023

    Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism

    DesfavorávelEstudo em AnimaisEfeitos Adversos da CannabisDependência — CannabisAnsiedade
  103. 2023

    Delta-8-THC association with psychosis: A case report with literature review

  104. 2023

    Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study

    FavorávelEnsaio ClínicoDorDependência QuímicaDisfunção CognitivaTHC Farmacêutico+1
  105. 2023

    Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership

    DesfavorávelEnsaio ClínicoDorDependência QuímicaEfeitos Adversos da Cannabis+4
  106. 2023

    Digital screening and brief intervention for illicit drug misuse in college students: A mixed methods, pilot, cluster, randomized trial from India

  107. 2023

    Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisPsicose+5
  108. 2023

    Drug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review

  109. 2023

    Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder

  110. 2023

    Effects of an App-Based Intervention Program to Reduce Substance Use, Gambling, and Digital Media Use in Adolescents and Young Adults: A Multicenter, Cluster-Randomized Controlled Trial in Vocational Schools in Germany

  111. 2023

    Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder

  112. 2023

    Effects of hypnosis, mindfulness meditation, and education for chronic pain on substance use in veterans: A supplementary analysis of a randomized clinical trial

    FavorávelEnsaio ClínicoDorDependência QuímicaDependência — Cannabis+3
  113. 2023

    Effects of sub-chronic nabiximols on biological markers of individuals undergoing a clinical trial for the treatment of cannabis use disorder

  114. 2023

    Effects of Δ9-THC and Type-1 Cannabinoid Receptor Agonists in the Elevated Plus Maze Test of Anxiety: A Systematic Review and Meta-Analysis

    DesfavorávelMetanáliseAnsiedade
  115. 2023

    Emerging adult perceptions of higher-risk cannabis consumption behaviours

  116. 2023

    Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

  117. 2023

    Enhancing Psychological Interventions for Post-Traumatic Stress Disorder (PTSD) Treatment with Memory Influencing Drugs

    FavorávelMetanáliseTEPT
  118. 2023

    Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  119. 2023

    Factors associated with suicide in people who use drugs: a scoping review

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+11
  120. 2023

    Financial incentives for smoking cessation in pregnancy: multicentre randomised controlled trial

  121. 2023

    Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials

    DesfavorávelMetanáliseTEPT
  122. 2023

    Gender differences in outcomes of early intervention services for first episode psychosis

    InconclusivoEnsaio ClínicoPsicoseEsquizofreniaTranstornos de Comportamento+2
  123. 2023

    Geriatric Pharmacotherapy Case Series: Potential Drug Interactions With Antiplatelet Medications and Cannabidiol-A Focus on P2Y12 Inhibitors

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)+3
  124. 2023

    Hippocampal CB1 receptor mediates antidepressant-like effect of synthetic cannabinoid-HU210 in acute despair reaction model in mice

    FavorávelEstudo em AnimaisDepressãoEstresse OxidativoCanabinoides Sintéticos HU-x
  125. 2023

    How are young people’s mental health related to their sexual health and substance use? A systematic review of UK literature

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+5
  126. 2023

    Impact of a brief distress intolerance intervention on acute stress modulation of response inhibition neurophysiology in cannabis use disorder

  127. 2023

    Impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder: A pilot, double-blind, placebo-controlled, randomized cross-over trial

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDisfunção CognitivaDependência — OpioidesCBD Farmacêutico+1
  128. 2023

    Impact of Harm Reduction Treatment with or without Pharmacotherapy on Polysubstance Use among People Experiencing Homelessness and Alcohol Use Disorder

  129. 2023

    Incidence and Persistence of Psychotic Experiences in the General Population: Systematic Review and Meta-Analysis

    DesfavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisPsicose
  130. 2023

    Induced negative affect's impact on self-reported cannabis use, expectancies, and problems

    DesfavorávelEnsaio ClínicoEfeitos Adversos da Cannabis
  131. 2023

    Induction of Anxiety-Like Phenotypes by Knockdown of Cannabinoid Type-1 Receptors in the Amygdala of Marmosets

    DesfavorávelEstudo em AnimaisAnsiedadeDepressãoDisfunção CognitivaEndocanabinoide (não especificado)+2
  132. 2023

    Inhaled Δ9-tetrahydrocannabinol does not enhance oxycodone-induced respiratory depression: randomised controlled trial in healthy volunteers

  133. 2023

    Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD)

    FavorávelEstudo LaboratorialDependência QuímicaDependência — Nicotina
  134. 2023

    Intervention for marijuana using, court-involved non-incarcerated youth

    InconclusivoEnsaio ClínicoDependência QuímicaEfeitos Adversos da Cannabis
  135. 2023

    Involvement of cannabinoid receptors and neuroinflammation in early sepsis: Implications for posttraumatic stress disorder

  136. 2023

    Keepin' It REAL-Mantente REAL in Mexico: Longitudinal Examination of Youth Drug Resistance Strategies and Substance Use Among Early Adolescents

  137. 2023

    Long-Term RCT outcomes for adolescent alcohol and cannabis use within a predominantly Hispanic sample

  138. 2023

    MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Oncológica
  139. 2023

    Measuring Readiness to Change Substance Use, Alcohol Use, and Cannabis Use: An Experimental Manipulation of Cognitive Effort

  140. 2023

    Measuring white matter microstructure in 1,457 cannabis users and 1,441 controls: A systematic review of diffusion-weighted MRI studies

  141. 2023

    Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic

    InconclusivoMetanáliseDependência QuímicaDependência — CannabisAnsiedade+7
  142. 2023

    Mixed Methods Evaluation of Satisfaction with Two Culturally Tailored Substance use Prevention Programs for American Indian/Alaska Native Emerging Adults

  143. 2023

    Moderating the impact of the COVID-19 pandemic on children's and adolescents' substance use, digital media use, and mental health: A randomized positive psychology addiction prevention program

    FavorávelEnsaio ClínicoDependência QuímicaCOVID-19
  144. 2023

    Molecular Insights into GPCR Mechanisms for Drugs of Abuse

  145. 2023

    Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression

    InconclusivoMetanálise ClínicaCâncerAnsiedadeDepressão+2
  146. 2023

    N-oleoyl glycine and N-oleoyl alanine attenuate alcohol self-administration and preference in mice

  147. 2023

    Negative experiences of patients using medicinal cannabis: A systematic review of qualitative studies

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  148. 2023

    Peer Network Counseling Effects on Substance Use: an Individual Participant Data Meta-Analysis Integrating Three Randomized Controlled Trials

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisDependência — Álcool+1
  149. 2023

    Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1-aging and epigenomics

  150. 2023

    Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection

    InconclusivoMetanálise ClínicaDorCâncerAnsiedadeTHC FarmacêuticoTHC:CBD Farmacêutico+10
  151. 2023

    Prevalence of cannabis use among young adults in Sweden comparing randomized response technique with a traditional survey

  152. 2023

    Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence

  153. 2023

    Recreational Cannabis Use Over Time in Individuals at Clinical High Risk for Psychosis: Lack of Associations with Symptom, Neurocognitive, Functioning, and Treatment Patterns

    InconclusivoMetanálisePsicoseEsquizofrenia
  154. 2023

    Relationship between patterns of cannabis use and functional and symptomatic trajectories in first-episode psychosis

    DesfavorávelEnsaio ClínicoDepressãoPsicoseEsquizofrenia
  155. 2023

    Results of a pilot study examining the effect of positive psychology interventions on cannabis use and related consequences

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  156. 2023

    Retrospective chart review of substance abuse in patients with psychiatric emergencies in an emerging urban county

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDependência — CannabisAnsiedade+9
  157. 2023

    Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial

  158. 2023

    Screening, brief intervention, and referral to treatment (SBIRT) for cannabis: A scoping review

  159. 2023

    Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics

  160. 2023

    Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

  161. 2023

    Smoked cannabis reduces peak cocaine plasma levels and subjective effects in a controlled drug administration study of polysubstance use in men

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  162. 2023

    Social media interventions addressing physical activity among emerging adults who use cannabis: A pilot trial of feasibility and acceptability

    FavorávelEnsaio ClínicoEfeitos Adversos da CannabisExercício Físico
  163. 2023

    Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior

  164. 2023

    Substance abuse and susceptibility to false memory formation: a systematic review and meta-analysis

  165. 2023

    Substance use and psychotic-like experiences in young people: a systematic review and meta-analysis

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+7
  166. 2023

    Substance-related cross-commodity purchase tasks: A systematic review

  167. 2023

    Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder

  168. 2023

    Systematic review of the efficacy, effectiveness, and cost-effectiveness of stepped-care interventions for the prevention and treatment of problematic substance use

  169. 2023

    Systematic Review: Polysubstance Prevalence Estimates Reported during Pregnancy, US, 2009-2020

  170. 2023

    The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção CognitivaPsicose+1
  171. 2023

    The association between callous-unemotional traits and substance use in childhood and adolescence: A systematic review and meta-analysis

    DesfavorávelMetanálise ClínicaDependência Química
  172. 2023

    The effect of recreational cannabis legalization and commercialization on substance use, mental health, and injury: a systematic review

    DesfavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisAnsiedade+2
  173. 2023

    The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study

    FavorávelMetanáliseAnsiedadeDepressãoNáusea e Vômito+2
  174. 2023

    The effectiveness of oxytocin for treating substance use disorders:A systematic review of randomized placebo-controlled trials

    InconclusivoMetanálise ClínicaDependência QuímicaDependência — CannabisAnsiedade+6
  175. 2023

    The Effects of Acute Cannabis With and Without Cannabidiol on Neural Reward Anticipation in Adults and Adolescents

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  176. 2023

    The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial

    FavorávelEnsaio ClínicoAnsiedadeDisfunção CognitivaTranstornos de Comportamento
  177. 2023

    The Effects of Long-Term Self-Dosing of Cannabidiol on Drowsiness, Testosterone Levels, and Liver Function

  178. 2023

    The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology

  179. 2023

    The Effects of β-myrcene on Simulated Driving and Divided Attention: A Double-Blind, Placebo-Controlled, Crossover Pilot Study

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção Cognitiva
  180. 2023

    The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders

    FavorávelEstudo em AnimaisDepressãoResveratrol
  181. 2023

    The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review

    DesfavorávelMetanáliseEfeitos Adversos da CannabisPsicoseNáusea e Vômito+1
  182. 2023

    The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial

  183. 2023

    Toxic Tetrahydrocannabinol (THC) Dose in Pediatric Cannabis Edible Ingestions

  184. 2023

    Use of psychoactive substances by goods carriage drivers associated with Kerala, India

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisDependência — CannabisPsicose+5
  185. 2023

    Using recovery management checkups for primary care to improve linkage to alcohol and other drug use treatment: a randomized controlled trial three month findings

  186. 2022

    "I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums

    FavorávelMetanáliseDependência QuímicaDependência — Opioides
  187. 2022

    [Effects of cannabis use on attention and memory in adolescent population: a systematic review]

  188. 2022

    [Inhaled marijuana and the lung, a toxic cocktail?]

    DesfavorávelMetanáliseCâncerEfeitos Adversos da CannabisDependência — Nicotina+2
  189. 2022

    #TurntTrending: a systematic review of substance use portrayals on social media platforms

  190. 2022

    A Case of Synthetic Cannabinoid (K2)-Induced Posterior Reversible Encephalopathy Syndrome (PRES)

  191. 2022

    A case report of clozapine-treatment-resistant schizophrenia successfully managed with brexpiprazole combination therapy

    DesfavorávelMetanáliseDependência — CannabisPsicoseEsquizofrenia+1
  192. 2022

    A national effectiveness trial of an eHealth program to prevent alcohol and cannabis misuse: responding to the replication crisis

  193. 2022

    A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ

  194. 2022

    A randomized controlled trial of social media interventions for risky drinking among adolescents and emerging adults

  195. 2022

    A randomized pilot trial of a mobile phone-based brief intervention with personalized feedback and interactive text messaging to reduce driving after cannabis use and riding with a cannabis impaired driver

    FavorávelEnsaio ClínicoEfeitos Adversos da Cannabis
  196. 2022

    A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History

    FavorávelEnsaio ClínicoEfeitos Adversos da CannabisTHC:CBD Farmacêutico
  197. 2022

    A social media intervention for cannabis use among emerging adults: Randomized controlled trial

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  198. 2022

    A Student Walks into Class … Vignettes to Identify Substance Use Disorder Models of Illness among College Students

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Opioides+3
  199. 2022

    A systematic review of substance use and substance use disorder research in Kenya

  200. 2022

    A systematic review of the efficacy, effectiveness and cost-effectiveness of workplace-based interventions for the prevention and treatment of problematic substance use

  201. 2022

    Acute and long-term exercise differently modulate plasma levels of oxylipins, endocannabinoids, and their analogues in young sedentary adults: A sub-study and secondary analyses from the ACTIBATE randomized controlled-trial

  202. 2022

    Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity

    DesfavorávelEnsaio Clínico Duplo-CegoEsquizofrenia
  203. 2022

    Acute pancreatitis as a rare adverse event among cannabis users: A systematic review

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da CannabisAnandamida (AEA)+17
  204. 2022

    Adaptive Treatment for Youth With Substance Use and Depression: Early Depression Response and Short-term Outcomes

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDepressão+1
  205. 2022

    Addiction and human male fertility: A systematic review and a critical appraisal

  206. 2022

    Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDepressãoDisfunção CognitivaPsicoseAnandamida (AEA)Palmitoiletanolamida (PEA)+4
  207. 2022

    Admissions to substance use treatment facilities for cannabis use disorder, 2000–2017: Does legalization matter?

    FavorávelMetanáliseDependência QuímicaDependência — Cannabis
  208. 2022

    Adolescent cannabis use and later development of schizophrenia: An updated systematic review of longitudinal studies

    DesfavorávelMetanáliseEfeitos Adversos da CannabisPsicoseEsquizofrenia
  209. 2022

    Adolescent Sibling Associations among Alcohol, Cannabis, and Sexual Risk Behavior: A Test of Interdependence

  210. 2022

    Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC

  211. 2022

    Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services

  212. 2022

    Adverse Effects of Cannabinoids and Tobacco Consumption on the Cardiovascular System: A Systematic Review

  213. 2022

    Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022)

    FavorávelMetanálise ClínicaEfeitos Adversos da CannabisCBD Farmacêutico
  214. 2022

    Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020

  215. 2022

    Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands

    InconclusivoEstudo em AnimaisTranstornos de ComportamentoEndocanabinoide (não especificado)
  216. 2022

    Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies

    FavorávelMetanálise ClínicaDependência QuímicaDependência — Opioides
  217. 2022

    Altered White Matter Integrity at Illness Onset in Adolescents With a First Episode of Psychosis

    InconclusivoEnsaio ClínicoPsicose
  218. 2022

    An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample

    FavorávelMetanáliseAnsiedadeDepressãoInsônia e Distúrbios do Sono
  219. 2022

    An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry

    FavorávelEnsaio ClínicoDorEfeitos Adversos da CannabisAnsiedade+4
  220. 2022

    Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects

  221. 2022

    Anhedonia, apathy, pleasure, and effort-based decision-making in adult and adolescent cannabis users and controls

    InconclusivoMetanáliseEfeitos Adversos da CannabisTranstornos de Comportamento
  222. 2022

    Anxiety and cognitive-related effects of Δ 9-tetrahydrocannabinol (THC) are differentially mediated through distinct GSK-3 vs. Akt-mTOR pathways in the nucleus accumbens of male rats

    InconclusivoEstudo em AnimaisAnsiedade
  223. 2022

    Anxiety sensitivity and cannabis use motives among trauma-exposed young adult cannabis users

    InconclusivoMetanáliseAnsiedade
  224. 2022

    Assessment of Delta-9-Tetrahydrocannabinol (THC) in Saliva and Blood After Oral Administration of Medical Cannabis With Respect to its Effect on Driving Abilities

  225. 2022

    Association between cannabis use and suicidal behavior: A systematic review of cohort studies

  226. 2022

    Association Between Prenatal Cannabis Use and Psychotropic Medication Use in Pregnant Patients With Depression and Anxiety

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+3
  227. 2022

    Association of cannabis potency with mental ill health and addiction: a systematic review

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisAnsiedadeTetraidrocanabinol (THC)+2
  228. 2022

    Associations between Cannabis Use, Cannabis Use Disorder and Mood Disorders: Longitudinal, Genetic, and Neurocognitive Evidence

    InconclusivoMetanáliseDependência QuímicaDependência — CannabisDepressão+2
  229. 2022

    Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort

  230. 2022

    Attention-Deficit Hyperactivity Disorder and Therapeutic Cannabis Use Motives

  231. 2022

    Autism and associated disorders: cannabis as a potential therapy

    FavorávelMetanáliseAutismoTetraidrocanabinol (THC)Canabidivarina (CBDV)
  232. 2022

    Ayahuasca-induced psychosis: A case report

    DesfavorávelMetanálisePsicoseEsquizofreniaAyahuasca
  233. 2022

    Ayahuasca-Induced Psychosis: A Case Report

    DesfavorávelMetanálisePsicoseInsônia e Distúrbios do SonoAyahuasca
  234. 2022

    Behavioral effects on the offspring of rodent mothers exposed to Tetrahydrocannabinol (THC): A meta-analysis

  235. 2022

    Brain morphology predictors of alcohol, tobacco, and cannabis use in adolescence: A systematic review

  236. 2022

    Can Intersectoral Interventions Reduce Substance Use in Adolescence? Evidence From a Multicentre Randomized Controlled Study

  237. 2022

    Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder

    DesfavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+4
  238. 2022

    Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists

    FavorávelMetanáliseAnsiedadeDepressão
  239. 2022

    Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function

    InconclusivoEnsaio ClínicoEfeitos Adversos da Cannabis
  240. 2022

    Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico

  241. 2022

    Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses

    FavorávelEstudo em AnimaisDependência QuímicaAnsiedadeDepressãoÁcido Canabidiólico (CBD-a)+5
  242. 2022

    Cannabidiol Effect on Anxiety Symptoms and Stress Response in Individuals With Cocaine Use Disorder: Exploratory Results From a Randomized Controlled Trial

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaAnsiedadeDependência — Cocaína
  243. 2022

    Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDisfunção CognitivaDependência — Cocaína
  244. 2022

    Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial

    DesfavorávelEnsaio Clínico Duplo-CegoAnsiedadeAnandamida (AEA)Canabinoide Sintético (não especificado)
  245. 2022

    Cannabidiol for the treatment of autism spectrum disorder: hope or hype?

  246. 2022

    Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial

    FavorávelEnsaio ClínicoAnsiedade
  247. 2022

    Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration-effect relations using the IB-de-risk tool

    InconclusivoMetanáliseAnsiedade
  248. 2022

    Cannabidiol in the context of substance use disorder treatment: A systematic review

  249. 2022

    Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study

  250. 2022

    Cannabidiol Increases Seizure Resistance and Improves Behavior in an Scn8a Mouse Model

    FavorávelEstudo em AnimaisEpilepsiaTranstornos de ComportamentoAutismo+1
  251. 2022

    Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway

    FavorávelEstudo LaboratorialDependência QuímicaDependência — Estimulantes
  252. 2022

    Cannabidiol Interferes with Establishment of Δ 9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT 1A Mechanism

  253. 2022

    Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice

  254. 2022

    Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department

  255. 2022

    Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence

  256. 2022

    Cannabinoid modulation of brain activation during volitional regulation of negative affect in trauma-exposed adults

    FavorávelEnsaio Clínico Duplo-CegoTEPTTetraidrocanabinol (THC)
  257. 2022

    Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance

  258. 2022

    Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports

    DesfavorávelMetanáliseEfeitos Adversos da CannabisPancreatiteTHC Farmacêutico
  259. 2022

    Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?

  260. 2022

    Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review

  261. 2022

    Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials

  262. 2022

    Cannabis and binge alcohol use among older individuals with major depressive episode

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisDepressão+1
  263. 2022

    Cannabis and the Violent Crime Surge

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDepressãoPsicose+5
  264. 2022

    Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis

    FavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedade
  265. 2022

    Cannabis for the Treatment of Attention Deficit Hyperactivity Disorder: A Report of 3 Cases

    FavorávelMetanáliseTDA e TDAH
  266. 2022

    Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms

    DesfavorávelMetanáliseEfeitos Adversos da CannabisPsicose
  267. 2022

    Cannabis smoking increases the risk of suicide ideation and suicide attempt in young individuals of 11-21 years: A systematic review and meta-analysis

    DesfavorávelMetanáliseEfeitos Adversos da CannabisTentativa de Suicídio
  268. 2022

    Cannabis use among U.S. military veterans with subthreshold or threshold posttraumatic stress disorder: Psychiatric comorbidities, functioning, and strategies for coping with posttraumatic stress symptoms

    DesfavorávelMetanáliseDorDependência — CannabisAnsiedade+4
  269. 2022

    Cannabis Use Among Young Adults in Washington State After Legalization of Nonmedical Cannabis

  270. 2022

    Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisPsicose
  271. 2022

    Cannabis use and patterns of psychotic symptomatology in a longitudinal birth cohort

    InconclusivoMetanáliseEfeitos Adversos da CannabisPsicoseEsquizofrenia
  272. 2022

    Cannabis use and related clinical variables in patients with obsessive-compulsive disorder

    InconclusivoEnsaio ClínicoTOC
  273. 2022

    Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study

  274. 2022

    Cannabis use and social anxiety in young adulthood: A meta-analysis

    DesfavorávelMetanáliseDependência — CannabisAnsiedade
  275. 2022

    Cannabis use and subjective response to alcohol in the human laboratory

  276. 2022

    Cannabis use and the risk of periodontitis: A two-sample Mendelian randomization study

  277. 2022

    Cannabis Use Disorder Is Associated With Longer In-Hospital Lengths of Stay, Higher Rates of Medical Complications, and Costs of Care Following Primary 1- to 2-Level Lumbar Fusion

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDependência — Cannabis
  278. 2022

    Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis

  279. 2022

    Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis

  280. 2022

    Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents

    InconclusivoEstudo em AnimaisPsicoseEsquizofrenia
  281. 2022

    Cannabis-Based Medicinal Products in the Management of Emotionally Unstable Personality Disorder (EUPD): A Narrative Review and Case Series

  282. 2022

    Capgras Syndrome Due to Cannabinoids Use: A Case Report With Radiological Findings

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadePsicose+2
  283. 2022

    Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations

  284. 2022

    Case report: Medical cannabis-warfarin drug-drug interaction

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  285. 2022

    Causal effects of cannabis legalization on parents, parenting, and children: A systematic review

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  286. 2022

    CB1 receptor antagonist AM4113 reverts the effects of cannabidiol on cue and stress-induced reinstatement of cocaine-seeking behaviour in mice

  287. 2022

    Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder

    InconclusivoEstudo em AnimaisTDA e TDAHEndocanabinoide (não especificado)
  288. 2022

    Central stress response among deprived and continuing marijuana users and nonusers

    InconclusivoEnsaio Clínico
  289. 2022

    Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints

    FavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+1
  290. 2022

    Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study

  291. 2022

    Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai'i who use cannabis: A matched cohort study

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+8
  292. 2022

    Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort

    InconclusivoEnsaio ClínicoTEPTAnandamida (AEA)Endocanabinoide (não especificado)+2
  293. 2022

    Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial

    FavorávelEnsaio ClínicoAnsiedadeDisfunção CognitivaInsônia e Distúrbios do Sono+1
  294. 2022

    Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders

    FavorávelMetanáliseAutismo
  295. 2022

    Clinical manifestations and serious adverse effects after cannabis use: role of age according to sex and coingestion of alcohol

    DesfavorávelEnsaio ClínicoDependência QuímicaEfeitos Adversos da CannabisPsicose+3
  296. 2022

    Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry

  297. 2022

    Cloudy with a chance of munchies: Assessing the impact of recreational marijuana legalization on obesity

    FavorávelMetanáliseEfeitos Adversos da CannabisObesidade
  298. 2022

    Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies

  299. 2022

    Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial

    FavorávelEnsaio ClínicoEfeitos Adversos da CannabisPsicose
  300. 2022

    Cognitive functioning and cannabis use in first-episode psychosis

    InconclusivoMetanálisePsicose
  301. 2019

    Impaired cognitive performance under psychosocial stress in cannabis-dependent men is associated with attenuated precuneus activity

    DesfavorávelEnsaio Clínico
  302. 2019

    Psychological wellbeing, burnout and substance use amongst medical students in New Zealand

    InconclusivoMetanálise
  303. 2019

    Serious psychological distress and daily cannabis use, 2008 to 2016: Potential implications for mental health?

    InconclusivoMetanálise
  304. 2018

    Responses to social evaluative stress in regular cannabis smokers

    InconclusivoEnsaio Clínico
  305. 2017

    Aromatherapy Improves Work Performance Through Balancing the Autonomic Nervous System

    FavorávelEnsaio Clínico Duplo-Cego
  306. 2017

    Blunted stress reactivity in chronic cannabis users.

    FavorávelEnsaio Clínico
  307. 2014

    Anti-stress effects of d-limonene and its metabolite perillyl alcohol.

    FavorávelEstudo em Animais
  308. 2011

    Chronic restraint stress impairs endocannabinoid mediated suppression of GABAergic signaling in the hippocampus of adult male rats

    FavorávelEstudo em Animais
  309. 2009

    Effect of Phytoncide From Trees on Human Natural Killer Cell Function

    FavorávelEnsaio Clínico

Continue por aqui

Perguntas frequentes

Quantos estudos sobre saúde mental e emocional estão indexados no acervo?
São 1.784 estudos, publicados entre 1871 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 824 · Ensaio Clínico: 329 · Estudo em Animais: 286 · Ensaio Clínico Duplo-Cego: 228 · Metanálise Clínica: 101 · Estudo Laboratorial: 15 · Ensaio Clínico Veterinário: 1. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 863 favoráveis, 395 inconclusivos e 526 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Saúde Mental e Emocional — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/sistema/saude-mental-e-emocional/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Saúde Mental e Emocional — estudos científicos sobre cannabis. https://cannabisindica.com.br/sistema/saude-mental-e-emocional/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.